Gavin Corcoran

Insider Reports History

Location
C/O Axovant Sciences, Inc., 11 Times Square, 33 Rd Floor, New York, NY
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gavin Corcoran:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. Director Common Stock 20 $13.00 $0.65 Mar 31, 2025 Direct
Verrica Pharmaceuticals Inc. Director Stock Option (right to buy) 20K Jun 5, 2025 Direct

Insider Reports Filed by Gavin Corcoran

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRCA Verrica Pharmaceuticals Inc. Jun 5, 2025 1 $0 4 Jun 9, 2025 Director
VRCA Verrica Pharmaceuticals Inc. Mar 31, 2025 1 $0 4 Apr 2, 2025 Director
VRCA Verrica Pharmaceuticals Inc. Mar 31, 2025 0 $0 3 Apr 2, 2025 Director